Agnes Gebhard is a Dutch medical doctor with a postgraduate specialization in Public Health. She joined KNCV as senior TB consultant in 2004 and became Technical Director in 2019.
She has 30 years of experience in Tropical Medicine, Public Health and Infectious Disease Prevention and Control. Having been based in Tanzania, Vietnam, Indonesia and The Netherlands, she has hands on experience in managing the TB elimination effort and provided substantial technical assistance to National TB programs in 15 countries in Africa, Central, Southern and East-Asia. She has developed, implemented and evaluated public health policies and disease-specific strategic plans and programs.
Since 2007 Agnes Gebhard regularly serves on advisory committees to WHO, mostly in the field of drug resistant TB and TB infection.
As Technical Director of KNCV, Agnes Gebhard focuses on delivery of quality services and technical assistance to countries, projects and partners, generation of (new) knowledge and evidence, design and implementation of demonstration projects and contributing to local and global policy development in support of the global TB elimination effort.
Current KNCV projects: oversight of the delivery of quality services and technical assistance to countries, projects and partners, generation of (new) knowledge and evidence, and contributing to local and global policy development in support of the global TB elimination effort. Provides technical backstopping to the whole technical division and is directly involved in introduction of 3HP (IMPAACT4TB projects), BPaL introduction with TB REACH and the TB Alliance ( LIFT-TB), capacity building and several other projects in The Netherlands, Asia, Africa, Central Asia.
Recent publications
Parwati CG, Farid MN, Nasution HS, Basri C, Gebhard A, Tiemersma EW et al. Estimation of subnational tuberculosis burden: generation and application of a new tool in Indonesia. Int J Tuberc Lung Dis. 2020;24(2):250-257. Abstract
Anh LTN, M V Kumar A, Ramaswamy G, Htun T, Quelapio M, Gebhard A, et al. High Levels of Treatment Success and Zero Relapse in Multidrug-Resistant Tuberculosis Patients Receiving a Levofloxacin-Based Shorter Treatment Regimen in Vietnam. Trop Med Infect Dis. 2020;5(1):43. Abstract
CG Edwards, F Wares, Dravniece, A. Gebhard, E Tiemersma, E van der Grinten et al. Introducing bedaquiline: experiences from the Challenge TB project. Int J Tuberc Lung Dis. 2020;24(10):1046-1053. Abstract/Full article
read all the KNCV publications